ANDA 85875, held by Watson Labs. Imipramine Hydrochloride.
As of Nov 16, 2026, ANDA 85875 (Imipramine Hydrochloride), held by Watson Labs, was first approved by FDA on Feb 4, 1981, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Feb 4, 1981 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Imipramine Hydrochloride10MG ยท tablet;oral | Imipramine Hydrochloride | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters